Related Experiment Video
Updated: Aug 13, 2026
08:49
Assessing Changes in Volatile General Anesthetic Sensitivity of Mice after Local or Systemic Pharmacological Intervention
Published on: October 16, 2013
Liver enzyme induction and inhibition: implications for anaesthesia
1Department of Anaesthesia, Poole and Royal Bournemouth Hospitals, Bournemouth BH7 7DW, UK. Bpsween@aol.com
Anaesthesia
|January 25, 2006
Summary
Molecular biology advances reclassified drug metabolising enzymes, improving understanding of drug metabolism and interactions. Enzyme induction and inhibition significantly affect anesthetic drug efficacy.
Area of Science:
- Molecular Biology
- Pharmacology
- Biochemistry
Background:
- Drug metabolising enzymes (DMEs) are crucial for drug metabolism and interactions.
- Recent molecular biology breakthroughs allow DME reclassification based on amino acid sequences.
- DMEs can be induced or inhibited by various substances, affecting drug efficacy.
Purpose of the Study:
- To review the classification of drug metabolising enzymes.
- To explain the mechanisms of enzyme induction and inhibition.
- To examine how these mechanisms alter the action of anesthetic drugs.
Main Methods:
- Literature review of recent breakthroughs in molecular biology and pharmacology.
- Analysis of enzyme classification based on amino acid sequences.
- Examination of induction and inhibition mechanisms.
- Case studies on anesthetic drugs (opioids, neuromuscular blockers).
Main Results:
- Reclassification of DMEs provides a clearer understanding of drug metabolism.
- Enzyme induction and inhibition are significant factors influencing drug responses.
- Anesthetic drug efficacy, including opioids and neuromuscular blockers, can be substantially altered.
Conclusions:
- Understanding DME classification and modulation is vital for optimizing anesthetic drug therapy.
- Awareness of enzyme induction/inhibition is critical for predicting and managing drug interactions in anesthesia.
- Further research into specific DME interactions with anesthetic agents is warranted.
Related Concept Videos
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
01:25Pharmacokinetics: Drug–Drug Interactions
Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
01:14Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug
In pharmacotherapy, monitoring drug concentrations is paramount, especially for drugs whose therapeutic effects hinge on both the active compound and its metabolite. Hepatic impairment profoundly influences drug potency by altering liver function. If the drug is more potent than its metabolite, impaired liver function amplifies drug activity due to elevated drug concentration levels. Conversely, if the metabolite holds greater potency, diminished liver function diminishes drug activity by...
01:13Local Anesthetics: Pharmacokinetics
The potency and duration of action of local anesthetics (LAs) are determined by their pharmacokinetics. Pharmacokinetics describes how LAs are absorbed, distributed, metabolized, and eliminated from the body. When administered to the vascular tissues, LAs are quickly absorbed and enter the systemic circulation, reducing their localized effects. Adding vasoconstrictors such as epinephrine to LAs reduces their absorption into the systemic circulation, making them clinically effective. The...
01:24Parenteral Anesthetics: Overview
Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.